title: Role of brain-derived neurotrophic factor in bone marrow angiogenesis in multiple myeloma.
abstract: This study examined the expression of brain-derived neurotrophic factor (BDNF) in multiple myeloma (MM) and its role in bone marrow angiogenesis. The peripheral blood plasma was harvested from 71 MM patients and 63 patients without hematological malignancy. The BDNF level in the blood plasma was determined by ELISA. Human bone marrow endothelial cells (HBMECs) were cultured. The mRNA and protein expression levels of the BDNF receptor TrkB in HBMECs were detected by using RT-PCR and flow cytometry, respectively. The viability of HBMECs treated with recombinant human (rh) BDNF or not was measured by using MTT assay. The migration of HBMECs in the presence of rhBDNF or not was determined by modified Boyden chamber assay. In vitro tube formation assay was used to assess the effect of rhBDNF on HBMECs differentiation. The results of ELISA revealed that the BDNF level was significantly higher in peripheral blood plasma of MM patients than in that of control patients (4.39±0.67 vs. 1.96±0.39 ng/mL, P<0.05). The BDNF receptor TrkB was expressed in HBMECs at mRNA and protein level. MTT assay manifested that rhBDNF could significantly concentration-dependently promote the HBMECs proliferation. The number of HBMECs treated with 160 ng/mL rhBDNF for 48 h was 1.57±0.10 folds higher than that in control group (P<0.05). Moreover, rhBDNF could enhance HBMECs migration in a concentration-dependent manner and the maximal migration was reached in the presence of 100 ng/mL rhBDNF. The migration indexes were 1.40±0.11, 1.64±0.16, 2.06±0.25 and 2.18±0.21 in 25, 50, 100 ng/mL rhBDNF groups and 25 ng/mL rhVEGF group, respectively. In vitro tube formation assay demonstrated that the area of the formed tubular structure was increased with the rhBDNF concentration. In control group, there was no formation of intact tubular structure and the HBMECs on the matrigel were irregularly dispersed. HBMECs treated with 100 ng/mL rhBDNF could form intact tubular structure and the area and the diameter of tubes were significantly greater than those in control group (P<0.05). There was no significant difference in the formed tubular area between 25 ng/mL VEGF group and 100 ng/mL rhBDNF group. It was concluded that BDNF plays an important role in myeloma cell-induced angiogenesis, and it may become a new target of anti-angiogenesis treatment for MM.
authors.affiliation: Institute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China.
authors.forename: Zhang-Bo
authors.initials: ZB
authors.lastname: Chu
authors.affiliation: Institute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China.
authors.forename: Chun-Yan
authors.initials: CY
authors.lastname: Sun
authors.affiliation: Institute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China.
authors.forename: Di
authors.initials: D
authors.lastname: Yang
authors.affiliation: Institute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China.
authors.forename: Lei
authors.initials: L
authors.lastname: Chen
authors.affiliation: Institute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China.
authors.forename: Yu
authors.initials: Y
authors.lastname: Hu
mesh_terms: D000328:Adult; D000368:Aged; D001853:Bone Marrow / Q000378:metabolism* / Q000473:pathology; D019208:Brain-Derived Neurotrophic Factor / Q000378:metabolism*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009101:Multiple Myeloma / Q000378:metabolism* / Q000473:pathology; D009389:Neovascularization, Pathologic / Q000378:metabolism* / Q000473:pathology
chemical_list: D019208:Brain-Derived Neurotrophic Factor; C579455:BDNF protein, human
references.citation: Haematologica. 2003 Feb;88(2):176-85
references.pmid: 12604407
references.citation: Cancer Microenviron. 2011 Dec;4(3):325-37
references.pmid: 21735169
references.citation: Cancer Res. 2006 Apr 15;66(8):4249-55
references.pmid: 16618748
references.citation: Clin Cancer Res. 2011 May 15;17(10):3123-33
references.pmid: 21421859
references.citation: Lung Cancer. 2013 Mar;79(3):205-14
references.pmid: 23312550
references.citation: Stem Cells. 2012 Feb;30(2):266-79
references.pmid: 22102554
references.citation: Br J Cancer. 2013 Jan 15;108(1):121-30
references.pmid: 23175149
references.citation: Oncol Rep. 2006 Dec;16(6):1237-43
references.pmid: 17089044
references.citation: Blood. 2009 Feb 26;113(9):2028-37
references.pmid: 19059881
references.citation: J Theor Biol. 2013 Jun 7;326:43-57
references.pmid: 23266714
references.citation: Am J Blood Res. 2011;1(1):76-89
references.pmid: 22432068
references.citation: Tissue Eng Part A. 2013 Aug;19(15-16):1655-64
references.pmid: 23530859
references.citation: PLoS One. 2012;7(1):e30246
references.pmid: 22276165
references.citation: Cell Biol Toxicol. 2005 Mar;21(2):127-37
references.pmid: 16142586
references.citation: Neuroscience. 2012 Aug 2;216:31-7
references.pmid: 22542551
references.citation: Blood. 2003 Apr 1;101(7):2775-83
references.pmid: 12517814
references.citation: Clin Cancer Res. 2009 Sep 1;15(17):5369-78
references.pmid: 19690192
references.citation: J Cell Mol Med. 2012 Dec;16(12):3105-15
references.pmid: 22925160
references.citation: Int J Oncol. 2012 Oct;41(4):1541-6
references.pmid: 22895657
references.citation: Cytokine Growth Factor Rev. 2012 Dec;23(6):357-65
references.pmid: 22749855
references.citation: Blood. 2003 Jul 15;102(2):638-45
references.pmid: 12649156
references.citation: Trends Cardiovasc Med. 2007 May;17(4):140-3
references.pmid: 17482097
references.citation: Lung Cancer. 2012 Oct;78(1):100-6
references.pmid: 22906736
references.citation: J Natl Cancer Inst. 2012 Jul 3;104(13):1005-20
references.pmid: 22745469
references.citation: Cancer Genet Cytogenet. 2007 Oct 1;178(1):1-10
references.pmid: 17889702
references.citation: Blood. 2006 Sep 1;108(5):1661-7
references.pmid: 16684957
references.citation: J Huazhong Univ Sci Technolog Med Sci. 2009 Apr;29(2):139-43
references.pmid: 19399393